Lee Johnson Capital Management LLC Invests $203,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Lee Johnson Capital Management LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 342 shares of the biotechnology company’s stock, valued at approximately $203,000. Axon Enterprise accounts for approximately 0.1% of Lee Johnson Capital Management LLC’s portfolio, making the stock its 29th biggest position.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. AHL Investment Management Inc. acquired a new position in Axon Enterprise in the 4th quarter valued at about $238,000. Trueblood Wealth Management LLC acquired a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $234,000. Artemis Investment Management LLP increased its holdings in shares of Axon Enterprise by 21.4% in the fourth quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company’s stock valued at $56,528,000 after purchasing an additional 16,792 shares during the period. Oak Ridge Investments LLC raised its stake in shares of Axon Enterprise by 5.4% during the fourth quarter. Oak Ridge Investments LLC now owns 15,153 shares of the biotechnology company’s stock worth $9,006,000 after purchasing an additional 782 shares during the last quarter. Finally, BNC Wealth Management LLC lifted its holdings in shares of Axon Enterprise by 4.5% during the fourth quarter. BNC Wealth Management LLC now owns 10,849 shares of the biotechnology company’s stock worth $6,448,000 after purchasing an additional 470 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $593.89 on Monday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company’s 50-day moving average price is $617.37 and its 200 day moving average price is $461.15. Axon Enterprise, Inc. has a 52 week low of $247.04 and a 52 week high of $698.67. The stock has a market cap of $45.28 billion, a price-to-earnings ratio of 153.46, a PEG ratio of 5.71 and a beta of 1.04.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Northland Securities upped their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. The Goldman Sachs Group raised their price target on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. JMP Securities upped their price objective on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Finally, Needham & Company LLC increased their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. One equities research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus target price of $504.92.

Insider Buying and Selling at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock valued at $30,721,337 over the last quarter. Corporate insiders own 5.70% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.